← Back to Clinical Trials
Recruiting NCT06384924

NCT06384924 Raman Spectroscopy and Skin Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06384924
Status Recruiting
Phase —
Sponsor Tiezhi Zhang
Condition Skin Cancer
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2025-02-13
Primary Completion 2027-02-13

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Raman Spectroscopy handheld probe (EmVision, FL, USA)Raman Spectroscopy laser source (Hubner Photonics Inc, CA, USA)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2025-02-13 with a primary completion date of 2027-02-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to find out if Raman Spectroscopy, a type of imaging, can be used to determine the size of skin cancer tumors. The main question it aims to answer is: -Can Raman Spectroscopy help figure out how far a tumor spreads? This study will take measurements using laser light from an experimental, handheld probe by lightly touching the skin.

Eligibility Criteria

Inclusion Criteria: * Histologically confirmed skin cancer (either basal cell carcinoma or squamous cell carcinoma) * Participants must plan to receive brachytherapy treatment for the skin cancer at the study site. * Ability to provide consent to the study. Exclusion Criteria: * Patient belongs to a vulnerable population (Minors (under 18 years old), Adults unable to consent, prisoners). * Lesions on the eyelid or in close proximity to the eye * Pregnant women, or women of childbearing age who refuse pregnancy testing. * Patient has pacemaker.

Contact & Investigator

Central Contact

Tiezhi Zhang

✉ tiezhi.zhang@stonybrookmedicine.edu

📞 631-444-3617

Principal Investigator

Tiezhi Zhang

PRINCIPAL INVESTIGATOR

Stony Brook Cancer Center

Frequently Asked Questions

Who can join the NCT06384924 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Skin Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06384924 currently recruiting?

Yes, NCT06384924 is actively recruiting participants. Contact the research team at tiezhi.zhang@stonybrookmedicine.edu for enrollment information.

Where is the NCT06384924 trial being conducted?

This trial is being conducted at Stony Brook, United States.

Who is sponsoring the NCT06384924 clinical trial?

NCT06384924 is sponsored by Tiezhi Zhang. The principal investigator is Tiezhi Zhang at Stony Brook Cancer Center. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology